CEO Werner Cautreels retiring; Iain Dukes appointed Interim CEO effective March 31, 2025

Traws Pharma, Inc.

Werner Cautreels to retire as CEO effective upon filing 2024 10-K around March 31; remains on board and as special advisor.
Iain Dukes, Executive Chairman, appointed Interim CEO; continues as Chairman.
Cautreels receives $10,000 lump sum and $10,000/month consulting fee for one year as special advisor.
No compensation changes for Dukes yet; amendment to his offer letter expected soon.
Investor update call scheduled for March 31, 2025 at 10:00 AM ET to review pipeline progress.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Werner Cautreels

Chief Executive Officer

TRAW · Traws Pharma, Inc.

Effective: 2025-03-31
Successor: Iain Dukes
Filed: March 28, 2025, 7:59 PM ET

On March 28, 2025, Werner Cautreels notified Traws Pharma, Inc. (the Company”) of his decision to retire and resign from his role as Chief Executive Officer of the Company, effective as of the close of business on the day that the Company files its Annual Report on Form 10-K for its 2024 fiscal year

Appointed (interim)

Iain Dukes

Interim Chief Executive Officer

TRAW · Traws Pharma, Inc.

Effective: 2025-03-31
Filed: March 28, 2025, 7:59 PM ET

Effective as of the Termination Date, the Board appointed Iain Dukes to serve as the Company’s Interim Chief Executive Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Werner Cautreels resigned as Chief Executive Officer at Traws Pharma, Inc..

Action: resigned
Role: Chief Executive Officer

Exact text from the filing

On March 28, 2025, Werner Cautreels notified Traws Pharma, Inc. (the Company”) of his decision to retire and resign from his role as Chief Executive Officer of the Company, effective as of the close of business on the day that the Company files its Annual Report on Form 10-K for its 2024 fiscal year

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Iain Dukes was appointed as Interim Chief Executive Officer at Traws Pharma, Inc..

Action: appointed
Role: Interim Chief Executive Officer

Exact text from the filing

Effective as of the Termination Date, the Board appointed Iain Dukes to serve as the Company’s Interim Chief Executive Officer.

View on SEC.gov

Traws Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-029405

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.